Despite stem cells reside in most of the adult tissues, their number is insufficient to regenerate/repair the damaged tissues. Hence the in-vitro culture and expansion is needed to obtain adequate number of cells for therapeutic applications. In this view, the primary objectives of NUCSReM involve the isolation, in-vitro culture, differentiation and autologous transplantation of patient specific stem cells. Further expansion of research aims to develop and utilise the patient specific induced pluripotent stem cells (iPSCs) based regenerative medicine technologies for the better treatment of diseases.
To realize the above research goals, the centre strictly follows the national and international standards of good manufacturing practice [GMP & current GMP (cGMP)] in which the cells are produced under the highest assurance of sterility, quality and documentation. The centre shall strictly abide by the ‘National Guidelines for Stem Cell Research-2013’ jointly issued by the Indian Council of Medical Research and the Department of Biotechnology (ICMR-DBT) and the regulations of concerned Indian organizations/authorities. Concerted efforts will also be made to promote and offer equitable access to the benefits of stem cell research.